55
PROBIOTICS & ANTIBIOTIC ASSOCIATED DIARRHOEA Dr Ajay Bhalla Add. Director & HOD Gastroenterology & Hepatology Fortis Hospital Noida

Dr ajay bhalla

Embed Size (px)

Citation preview

  1. 1. Dr Ajay Bhalla Add. Director & HOD Gastroenterology & Hepatology Fortis Hospital Noida
  2. 2. World Health Organization: live microorganisms which when administered in adequate amounts confer a health benefit on the host They: Survive stomach acid and bile Establish residence in the intestines Impart health benefits
  3. 3. Products containing BOTH Prebiotics Probiotics
  4. 4. Lactobacillus sp. reuteri casei ramnosus Acidophilus Streptococcus sp. Bifidobacterium sp. Infantis (breastmilk) lactis longum breve bifidum Sacharomyces boulardii Enterococcus sp Mixtures Formulations: drops, chewable tablets, lozenges, capsules, straws, bottle caps
  5. 5. Eli Metchnikoff - early 20th century (Russian Nobel laureate, professor at Pasteur Institute in Paris) Observed Bulgarians who drank milk fermented by lactic-acid producing bacteria had long lives Lactic acid lowers gut pH and inhibits the growth of some pathogenic bacteria. Metchnikoff began drinking fermented milk and soon Parisian physicians did likewise. Henry Tissier at Pasteur Institute identified bacteria common in breastfed infant stool: Bifidobacter Lactobacillus acidophilus breaks down lactose and allows lactose intolerant individuals to drink milk
  6. 6. Colonization at birth with maternal species Specific organisms vary by age in first year Become established by 1 year Diet maternal milk, fermented milk, pickles, fermented soy (tempeh), etc. Successful probiotic treatment leads to temporary colonization
  7. 7. After reviewing a majority of the research and literature relative to probiotic use in humans, it is clear that diarrhea is the condition most beneficially treated by probiotic therapy. This can include diarrhea associated with antibiotics, travel, gastroenteritis, lactose intolerance, and Inflammatory Bowel Disease. These areas were reviewed.
  8. 8. Diarrhea is frequent loose stools, along with an excessive loss of fluid and electrolytes (K & Na especially), abdominal cramping, pain, and often presence of a fever. It can be acute or chronic, and is secondary to an underlying disease or condition or pathogenic bacteria within the GI tract.
  9. 9. Protection of intestinal epithelial barrier function Regulation of intestinal epithelial homeostasis Regulation of intestinal microbial environment Modifications to commensal and probiotic bacteria to enhance diarrhea prevention
  10. 10. integrity of the gastrointestinal epithelium L. acidophilus; S. thermophilus, prevent enteroinvasive E. coli disruption of intestinal epithelial barrier function VSL#3 enhances T84 tight junctions Salmonella dublin L. acidophilus p38 mitogen activated protein kinase and Akt signal transduction pathways prevent cytokine-induced increases in intestinal epithelial paracellular permeability
  11. 11. Inflammatory cytokines and chemokines intestinal epithelial cell injury. L. casei downregulates Shigella flexneri by inhibition of NFB-dependent transcription LGG prevents cytokine-induced intestinal epithelial injury 1.by preventing apoptosis and promoting cell growth 2.cytoprotective shock proteins
  12. 12. Disturbing the balance between the host and commensal bacterial flora in GI tract is associated with antibiotic-associated diarrhea fungal infections L. acidophilus and Bifidobacterium spp. 1.prevent antibiotic treatment-induced increases in facultative anaerobic bacteria 2.decrease antibiotic-resistant enterococci.
  13. 13. toxin-receptor blockade strategy recombinant E. coli is able to produce a lipopolysaccharide, which can bind heat- labile enterotoxin, induces travelers diarrhea virulent V. cholerae cholera toxin
  14. 14. Antibiotic-associated diarrhea (AAD) and Clostridium difficile infection major pathological bacteria Lactobacillus GG (LGG) Saccharomyces boulardii 1.significantly reduced the incidence of antibiotic- associated diarrhea from 18.9% (placebo) to 5.7% (P < 0.05) 2.combination with susceptible antibiotics decreases recurrence of C. difficile infection
  15. 15. Administration of LGG, Saccharomyces boulardii, before and during antibiotic treatment reduced the frequency and/or duration of episodes and the severity of symptoms in many cases but was not always effective Eradication Helicobacter pylori using clarithromycin, amoxicillin, and omeprazol leads to diarrheas Coadministration of S. boulardii during H. pylori eradication did reduce AAD from 11.5 to 6.9%
  16. 16. AAD is defined as unexplained diarrhoea which develops within few hours following antibiotic use upto 8 weeks after antibiotic discontinuation
  17. 17. Its incidence has been noted to slowly increase over the past few years, reaching up to 30% in some instances. Symptoms can vary from mild self-limited disease to the more serious and severe Clostridium difficile (C. difficile)-associated diarrhea (CDAD). Luckily, CDAD is only responsible for an estimated 10%-20% of cases of AAD Multiple risk factors for CDAD have been delineated, such as advanced age, hospitalization, acid suppression, chemotherapy, renal failure, gastrointestinal surgery and mechanical ventilation
  18. 18. Common signs and symptoms For most people, antibiotic-associated diarrhea causes mild signs and symptoms, such as: Loose stools More-frequent bowel movements More-serious signs and symptoms Some patients may have signs and symptoms of colitis or pseudomembranous colitis, such as: Frequent, watery diarrhea Abdominal pain and cramping Fever Mucus in your stool Bloody stools Nausea Loss of appetite
  19. 19. Nearly all antibiotics can cause antibiotic- associated diarrhea, colitis or pseudomembranous colitis. The antibiotics most commonly linked to antibiotic-associated diarrhea include: Cephalosporins, such as cefixime,Cefuroxime and cefpodoxime Clindamycin Penicillins, such as amoxicillin and ampicillin Macrolides(Erythromycin) Fluoroquinolones, such as ciprofloxacin (Cipro) and levofloxacin
  20. 20. 20-30% of antibiotic-associated diarrhea Toxins detectable in stool Onset during or within 10 weeks antibiotic use Associated with all antibiotics 4 categories based on colon appearance Normal colonic mucosa Mild erythema with some edema Granular, friable, or hemorrhagic mucosa Pseudomembrane formation - mucosa shows raised plaques with skip areas
  21. 21. Diverse clinical spectrum Diarrhea may be profuse/watery Blood or mucus may be present Abdominal cramps Fever & leukocytosis Large numbers of RBCs and WBCs in stool 95% have positive stool toxin assays C. difficile toxin is very unstable Toxin degrades at room temperature and may be undetectable within 2 hours after collection of a stool specimen False-negative results occur when specimens are not promptly tested or kept refrigerated until testing can be done
  22. 22. Pseudomembraneous colitis Toxic megacolon Perforation of the colon Sepsis Death
  23. 23. ANTIBIOTIC EXPOSURE Gastrointestinal surgery or manipulation Long length of stay in healthcare setting Infected roommate Co-morbid illnesses Immunosuppression Advanced age Proton-pump inhibitors and H2-blockers?
  24. 24. MORE FREQUENT LESS FREQUENT Cephalosporins (3rd and 4th generation) Ticarcillin-clavulanate Ampicillin/Amoxicillin Metronidazole Clindamycin Fluoroquinolones Other penicillins Rifampin Macrolides 5-Fluorouracil Tetracyclines Methotrexate Trimethoprim-Sulfamethoxazole Cyclophosphamide
  25. 25. Enhanced infection control measures. Targeted antibiotic restriction Appropriate antibiotic therapy Adjunctive therapy probiotics, IVIG, toxin binders Avoid antiperistaltic and opiate drugs. Fecal transplantation
  26. 26. Systematic review of 9 placebo-controlled studies (2 in children) using various products: 60% reduction in incidence and duration of antibiotic associated diarrhea compared with placebo (P